CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Revenue

CanSino Biologics had revenue of 245.17M CNY in the quarter ending June 30, 2025, with 29.62% growth. This brings the company's revenue in the last twelve months to 925.24M, up 45.80% year-over-year. In the year 2024, CanSino Biologics had annual revenue of 846.34M with 137.01% growth.

• Revenue (ttm): 925.24M CNY
• Revenue Growth: +45.80%
• P/S Ratio: 16.28
• Revenue / Employee: 837.32K CNY
• Employees: 1,105
• Market Cap: 16.51B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	846.34M	489.25M	137.01%
Dec 31, 2023	357.08M	-677.51M	-65.49%
Dec 31, 2022	1.03B	-3.27B	-75.94%
Dec 31, 2021	4.30B	4.27B	17,174.82%
Dec 31, 2020	24.89M	9.28M	59.43%